Pierre Laurin

Founder at Liminal BioSciences, Inc.

Pierre Laurin

Pierre Laurin

Founder at Liminal BioSciences, Inc.

Overview
Career Highlights

Merrill Lynch & Co. Canada Ltd.
Soccrent, Inc.
La Société en Commandite Soccrent Nouvelles Technologies

RelSci Relationships

303

Number of Boards

13

Birthday

1961

Age

58

Contact Data
Trying to get in touch with Pierre Laurin? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Pierre Laurin likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Quebecor Inc.

Relationship likelihood: Strong

Chief Executive Officer at Liminal BioSciences, Inc.

Relationship likelihood: Strong

Chief Strategy Officer at Hepalink USA, Inc.

Relationship likelihood: Strong

Chief Investment Officer & Managing Director at Thomvest Asset Management, Inc.

Relationship likelihood: Strong

Consulting Professor at Stanford University

Relationship likelihood: Strong

Visiting Professor of Medicine at University of Edinburgh Medical School

Relationship likelihood: Strong

Former Interim Chief Financial Officer at Redline Communications Group, Inc.

Relationship likelihood: Strong

Former Chief Communications Officer at The Bell Telephone Company of Canada

Relationship likelihood: Strong

Founder at Huis Clos Ltee

Relationship likelihood: Strong

Chief Operating Officer-International at Liminal BioSciences, Inc.

Relationship likelihood: Strong

In The News
Paths to Pierre Laurin
Potential Connections via
Relationship Science
You
Pierre Laurin
Founder at Liminal BioSciences, Inc.
Education
Master Degree in Pharmaceutical Sciences

The Université de Montréal is a public research university in Montreal, Quebec, Canada. The francophone institution comprises thirteen faculties, more than sixty departments and two affiliated schools: the École Polytechnique (School of Engineering) and HEC Montréal (School of Business). It offers more than 650 undergraduate programmes and graduate programmes.

Memberships
Career History
Vice President-Planning & Administration
Prior

Alcan Inc. produces aluminum products and packaging materials. The company controls 13% of the world's aluminum production capacity. It mines bauxite (aluminum ore) and makes and recycles aluminum sheet, foil, wire and cable, and extrusions (doors, windows, auto parts). It also generates hydroelectric power and makes aluminum-related specialty chemicals and packaging products. It is headquartered in Montreal, Canada.

President
Prior

The Group's principal activities are to provide investment, financing, advisory, insurance and related products and services on a global basis. The Group's services includes securities brokerage, trading, insurance, record keeping and underwriting through its broker, dealer, banking, insurance and other financial services subsidiaries. The Group operates in three business segments: Global Markets and Investment Banking group, Global Private Client, and Merrill Lynch Investment Managers. The principal subsidiary of the Group is Merrill Lynch, Pierce, Fenner & Smith Inc., which provides securities brokerage, option contracts, commodity and financial futures contracts, selected insurance products, options, corporate and municipal securities, investment banking and business advisory services. The Group operates in Europe, Middle East, and Africa, Pacific Rim, Canada and Latin America. In 2005, the Group acquired Pax Clearing Corp, the advest Group and Amvescap Plc.

Founder
1994 - 2018

Liminal BioSciences, Inc. is a biopharmaceutical corporation, which engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer. It operates through the following segments: Bioseparations, Plasma-derived Therapeutics, and Small Molecule Therapeutics. The Bioseparations segment offers prometic's core bioseparation technologies and products. The Plasma-derived Therapeutics segment provides efficient extraction and purification of therapeutic proteins from human plasma. The Small Molecule Therapeutics segment manufactures drug candidates such as PBI-4050, PBI-4547, and PBI-4425. The company was founded on October 14, 1994 and is headquartered in Quebec, Canada.

Boards & Committees
Independent Director
2019 - Current

Ortho Regenerative Technologies, Inc. engages in the development of novel therapeutic soft tissue repair technologies for sports medicine surgeries. Its product pipeline include Rotator Cuff Repair, and R&D Portfolio. The company was founded on February 5, 2015 and is headquartered in Kirkland, Canada.

Director
2016 - Current

Prometic Pharma SMT Ltd., a subsidiary of Prometic Biosciences, Inc., is a British company located in Comberton involved in biological products, except diagnostic substances. It was founded in 2015.

Member, Board of Directors
Prior - 2018

Liminal BioSciences, Inc. is a biopharmaceutical corporation. The firm engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer. It operates through the following segments: Bioseparations, Plasma-derived Therapeutics, and Small Molecule Therapeutics. The Bioseparations segment offers prometic's core bioseparation technologies and products. The Plasma-derived Therapeutics segment provides efficient extraction and purification of therapeutic proteins from human plasma. The Small Molecule Therapeutics segment manufactures drug candidates such as PBI-4050, PBI-4547, and PBI-4425. The company was founded on October 14, 1994 and is headquartered in Laval, Canada.

Member, Board of Directors
Prior

HEC Montréal is a university business school whose reputation as a leader in teaching and research is recognized in Québec, Canada, and around the world. HEC Montréal is a French-language university institution offering internationally renowned management education and research. The School has been training future managers who contribute to our society’s growth and prosperity, since 1907. HEC Montréal’s excellence in management teaching and research is recognized worldwide. As proof, the School was the first in North America to be awarded the three most prestigious international accreditations in its field: AACSB International, EQUIS and AMBA. HEC Montréal is a French-language institution solidly rooted in its community and open to the world. It is an international-calibre university business school that contributes to our society’s prosperity by providing leadership in all its spheres of activity, i.e. teaching at all levels, research and serving the community.

Investments
Details Hidden
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pierre Laurin. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pierre Laurin's profile does not indicate a business or promotional relationship of any kind between RelSci and Pierre Laurin.